Alkermes plc. (32) | Collaboration Agreements (3)
- Fourth Amendment to License and Collaboration Agreement between Alkermes Pharma Ireland Limited and Biogen Swiss Manufacturing GmbH, effective as of August 25, 2022 (Filed With SEC on November 2, 2022)
- In accordance with Item 601(b)(2)(ii) of Regulation S-K, certain information (indicated by [**]) has been excluded from this exhibit because it is both not material and would... (Filed With SEC on February 13, 2020)
- Second Amendment, effective as of January 31, 2019, to License and Collaboration Agreement by and between Alkermes Pharma Ireland Limited and Biogen Swiss Manufacturing GmbH dated... (Filed With SEC on April 25, 2019)
